News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Daily News Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review Caitlin E. Cox July 11, 2023
News Conference News ESOC 2023 Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting Todd Neale June 02, 2023
News Conference News ESOC 2023 TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes Todd Neale May 31, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2023 Shelley Wood May 31, 2023
News Conference News SCAI 2023 Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI L.A. McKeown May 24, 2023
News Daily News Aortic Disease Deaths Tied to Modifiable Risk Factors, Japanese Data Confirm Caitlin E. Cox April 18, 2023
News Daily News MR CLEAN-LATE Affirms 24-Hour Window Safe for Endovascular Stroke Therapy Yael L. Maxwell April 07, 2023
News Conference News ISC 2023 AHA Issues Recommendations for Structuring Stroke Programs Todd Neale February 16, 2023
News Conference News ISET 2023 Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine Caitlin E. Cox January 26, 2023
News Conference News ISET 2023 ‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role Caitlin E. Cox January 18, 2023
News Daily News Ralph Sacco, Neurologist and AHA Past President, Dies of Brain Cancer Shelley Wood January 17, 2023
News Conference News ISET 2023 As Outpatient Facilities Proliferate, So Too Does Scrutiny Caitlin E. Cox January 17, 2023
News Conference News ISET 2023 For Vascular Labs, Accreditation Drives Quality and Objectivity Caitlin E. Cox January 17, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2022 Shelley Wood January 03, 2023
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022